FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

713226004: Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3708739017 Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3708740015 Bendroflumethiazide- and nadolol-containing product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5468061000241114 produit contenant du bendrofluméthiazide et du nadolol sous forme orale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) Is a Product containing bendroflumethiazide and nadolol (medicinal product) true Inferred relationship Some
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) Is a Product manufactured as oral dose form (product) false Inferred relationship Some
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Nadolol (substance) true Inferred relationship Some 1
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bendroflumethiazide (substance) true Inferred relationship Some 2
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) Has manufactured dose form Oral dose form true Inferred relationship Some
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) Is a Bendroflumethiazide-containing product in oral dose form true Inferred relationship Some
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) Is a Nadolol-containing product in oral dose form true Inferred relationship Some
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) Plays role Diuretic therapeutic role false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet Is a False Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) Inferred relationship Some
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug) Is a False Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) Inferred relationship Some
Bendroflumethiazide and nadolol only product in oral dose form Is a True Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) Inferred relationship Some

This concept is not in any reference sets

Back to Start